NCT00275561View on ClinicalTrials.gov

Topical Steroid Treatment for Eosinophilic Esophagitis

PHASE2CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Eosinophilic Esophagitis

Interventions

DRUG

Fluticasone

Aerosolized swallowed fluticasone 880 mg twice a day

DRUG

Placebo

Placebo inhaler swallowed twice a day for 6 weeks

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER